Psychedelic Bulletin #144: Otsuka to Buy Mindset; Responses to FDA Draft Guidance; Cybin to Acquire Small Pharma; Usona Publishes Phase 2 Study

This Issue: and lots more… ● Big Pharma Co. Otsuka Acquires Mindset● Cybin Acquires Small Pharma● COMPASS Pathways Raises $125m● Usona Institute Publishes Phase 2 Study of Psilocybin for Major Depressive Disorder● UK Cross-Party Committee Recommends Rescheduling Psychedelics ● Adult Cannabis and Psychedelic Use is at “Record High” Toronto-based Mindset Pharma is set to be acquired by the U.S.

Source